National health services pumps in £20m (US$23m) to help improve cancer diagnosis

UK – The National Health Services is investing £20m (US$23m) into the British health system in a bid to measures for rapid cancer diagnosis and have more patients get checked for cancer. Among the measures included in the package is tele dermatology, which is being used to diagnose skin cancer rapidly. The funding will also be used to help speed up diagnosis for prostate cancer, by referring patients directly for an MRI scan by nurses rather than waiting for an appointment with a consultant. Other measures include a cancer symptom…

Read More

GE Healthcare’s newly integrated deep learning solution will improve accuracy for radiation oncology treatment

US – GE Healthcare will integrate Spectronic Medical AB’s, a Swedish based med tech company, AI-based software into AIR Recon Deep Learning (DL) technology in a bid to improve cancer treatment with precise planning. This AI solution, in combination with GE Healthcare’s industry leading AIR Recon DL technology, enables MR-only based radiotherapy planning for better soft tissue differentiation than traditional CT, so clinicians can better direct radiotherapy. The solution will provide high quality images to precisely target lesions while sparing healthy tissue that around 60% of cancer patients need in…

Read More

Biogen signs collaborative agreement with Innocare to use orelabrutinib as potential therapy for multiple sclerosis

WORLD – Biogen and Innocare, a biopharmaceutical company rooted in China, have signed a license and a collaboration agreement for the use of Orelabrutinib that could potentially be used to treat multiple sclerosis. Under the terms of the agreement, Biogen will have exclusive rights to orelabrutinib in the field of MS worldwide and certain autoimmune diseases outside of China, while Innocare will retain exclusive worldwide rights to orelabrutinib in the field of oncology and certain autoimmune diseases in China. InnoCare will receive a US$125M upfront payment and is eligible to…

Read More